15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping

Source provenance

Verified Bibliography

A library-wide index of source records whose PubMed identifiers, DOI metadata, and titles have local verification receipts.

131 sources

  1. Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

    Merlino F, Jia L, Boccino I, Carotenuto A, Tammaro F, Santoro F, Thompson PE, Grieco P

    Journal of medicinal chemistry · 2026-08-13 · Journal Article

    current
  2. Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.

    Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, Lutz TA, Le Foll C

    EBioMedicine · 2025-07-03 · Journal Article

    current
  3. Molecular recognition of two approved drugs Macimorelin and Anamorelin by the growth hormone secretagogue receptor.

    Wang RL, Sun J, Liu H, Guo SM, Zhang Y, Hu W, Wang J, Liu H, Zhuang YW, Jiang Y, Xie X, Xu HE, Wang Y

    Acta pharmacologica Sinica · 2025-06-20 · Journal Article

    current
  4. Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS/MS.

    Becker JO, Shijo SK, Huynh HH, Forrest KL, MacCoss MJ, Emrick MA, Goonatilleke E, Hoofnagle AN

    Journal of mass spectrometry and advances in the clinical lab · 2025-04-11 · Journal Article

    current
  5. Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.

    Cao J, Belousoff MJ, Johnson RM, Keov P, Mariam Z, Deganutti G, Christopoulos G, Hick CA, Reedtz-Runge S, Glendorf T, Ballarín-González B, Raun K, Bayly-Jones C, Wootten D, Sexton PM

    Nature communications · 2025-04-10 · Journal Article

    current
  6. Glucose-dependent insulinotropic polypeptide (GIP).

    Müller TD, Adriaenssens A, Ahrén B, Blüher M, Birkenfeld AL, Campbell JE, Coghlan MP, D'Alessio D, Deacon CF, DelPrato S, Douros JD, Drucker DJ, Figueredo Burgos NS, Flatt PR, Finan B, Gimeno RE, Gribble FM, Hayes MR, Hölscher C, Holst JJ, Knerr PJ, Knop FK, Kusminski CM, Liskiewicz A, Mabilleau G, Mowery SA, Nauck MA, Novikoff A, Reimann F, Roberts AG, Rosenkilde MM, Samms RJ, Scherer PE, Seeley RJ, Sloop KW, Wolfrum C, Wootten D, DiMarchi RD, Tschöp MH

    Molecular metabolism · 2025-02-28 · Review

    current
  7. The structure and function of the ghrelin receptor coding for drug actions.

    Shiimura Y, Im D, Tany R, Asada H, Kise R, Kurumiya E, Wakasugi-Masuho H, Yasuda S, Matsui K, Kishikawa JI, Kato T, Murata T, Kojima M, Iwata S, Masuho I

    Nature structural & molecular biology · 2025-01-20 · Journal Article

    current
  8. The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron.

    Sloop KW, Cox AL, Wainscott DB, White A, Droz BA, Stutsman C, Showalter AD, Suter TM, Dunbar JD, Snider BM, O'Farrell LS, Hewitt N, Ruble JC, Padgett LR, Woerly EM, Peterson JA, Coskun T, Liu Z, Coutant DE, Ai M, Emmerson PJ, Sangwung P, Willard FS

    Science translational medicine · 2024-12-18 · Journal Article

    current
  9. Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder.

    Mottolese N, Loi M, Trazzi S, Tassinari M, Uguagliati B, Candini G, Iqbal K, Medici G, Ciani E

    Journal of neurodevelopmental disorders · 2024-11-26 · Journal Article

    current
  10. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.

    Sturaro C, Ruzza C, Ferrari F, Pola P, Argentieri M, Frezza A, Marzola E, Bettegazzi B, Cattaneo S, Pietra C, Malfacini D, Calò G

    European journal of pharmacology · 2024-08-10 · Journal Article

    current
  11. Investigating the detection of the novel doping‐relevant peptide kisspeptin‐10 in urine using liquid chromatography high‐resolution mass spectrometry.

    Colpaert T, Risseeuw M, Deventer K, Van Eenoo P

    Biomedical chromatography : BMC · 2024-07-08 · Journal Article

    current
  12. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

    Sanyal AJ, Kaplan LM, Frias JP, Brouwers B, Wu Q, Thomas MK, Harris C, Schloot NC, Du Y, Mather KJ, Haupt A, Hartman ML

    Nature medicine · 2024-06-10 · Clinical Trial, Phase II

    current
  13. Spexin Diminishes Atrial Fibrillation Vulnerability by Acting on Galanin Receptor 2.

    Li D, Liu Y, Li C, Zhou Z, Gao K, Bao H, Yang J, Xue G, Yin D, Zhao X, Shen K, Zhang L, Li J, Li C, Song J, Zhao L, Pei Y, Xuan L, Zhang Y, Lu Y, Zhang ZR, Yang B, Li Y, Pan Z

    Circulation · 2024-05-10 · Journal Article

    current
  14. The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.

    Thomas L, Martel E, Rist W, Uphues I, Hamprecht D, Neubauer H, Augustin R

    Diabetes, obesity & metabolism · 2024-04-01 · Journal Article

    current
  15. Ultrasensitive and Label-Free Detection of Copper Ions by GHK-Modified Asymmetric Nanochannels.

    An P, Zhang Z, Yang J, Wang T, Wang Z, Sun CL, Qin C, Li J

    Analytical chemistry · 2023-08-25 · Journal Article

    current
  16. Structural analysis of the dual agonism at GLP-1R and GCGR.

    Li Y, Zhou Q, Dai A, Zhao F, Chang R, Ying T, Wu B, Yang D, Wang MW, Cong Z

    Proceedings of the National Academy of Sciences of the United States of America · 2023-08-07 · Journal Article

    current
  17. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

    Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T

    Lancet (London, England) · 2023-06-26 · Clinical Trial, Phase II

    current
  18. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

    Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML, Retatrutide Phase 2 Obesity Trial Investigators

    The New England journal of medicine · 2023-06-26 · Clinical Trial, Phase II

    current
  19. Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1.

    Luo P, Feng W, Ma S, Dai A, Wu K, Chen X, Yuan Q, Cai X, Yang D, Wang MW, Eric Xu H, Jiang Y

    Cell research · 2023-01-02 · Journal Article

    current
  20. BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.

    Zimmermann T, Thomas L, Baader-Pagler T, Haebel P, Simon E, Reindl W, Bajrami B, Rist W, Uphues I, Drucker DJ, Klein H, Santhanam R, Hamprecht D, Neubauer H, Augustin R

    Molecular metabolism · 2022-11-07 · Journal Article

    current
  21. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

    Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z

    Cell metabolism · 2022-08-18 · Journal Article

    current
  22. Structural determinants of dual incretin receptor agonism by tirzepatide.

    Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW

    Proceedings of the National Academy of Sciences of the United States of America · 2022-03-25 · Journal Article

    current
  23. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.

    Tomassi S, Dimmito MP, Cai M, D'Aniello A, Del Bene A, Messere A, Liu Z, Zhu T, Hruby VJ, Stefanucci A, Cosconati S, Mollica A, Di Maro S

    Journal of medicinal chemistry · 2022-02-21 · Journal Article

    current
  24. Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.

    Heyder NA, Kleinau G, Speck D, Schmidt A, Zschunke S, Szczepek M, Bauer B, Koch A, Gallandi M, Kwiatkowski D, Bürger J, Mielke T, Beck-Sickinger AG, Hildebrand PW, Spahn CMT, Hilger D, Schacherl M, Biebermann H, Hilal T, Kühnen P, Kobilka BK, Scheerer P

    Cell research · 2021-09-24 · Journal Article

    current
  25. Structural mechanism of calcium-mediated hormone recognition and Gβ interaction by the human melanocortin-1 receptor.

    Ma S, Chen Y, Dai A, Yin W, Guo J, Yang D, Zhou F, Jiang Y, Wang MW, Xu HE

    Cell research · 2021-08-27 · Journal Article

    current
  26. Structural insights into ligand recognition and activation of the melanocortin-4 receptor.

    Zhang H, Chen LN, Yang D, Mao C, Shen Q, Feng W, Shen DD, Dai A, Xie S, Zhou Y, Qin J, Sun JP, Scharf DH, Hou T, Zhou T, Wang MW, Zhang Y

    Cell research · 2021-08-25 · Journal Article

    current
  27. Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor.

    Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, He X, Guo J, Yin W, Xu HE, Xie X, Jiang Y

    Nature communications · 2021-08-20 · Journal Article

    current
  28. Development of Cagrilintide, a Long-Acting Amylin Analogue.

    Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K

    Journal of medicinal chemistry · 2021-07-21 · Journal Article

    current
  29. Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes.

    Zhang X, Belousoff MJ, Liang YL, Danev R, Sexton PM, Wootten D

    Cell reports · 2021-07-13 · Journal Article

    current
  30. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

    Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P

    Frontiers in pharmacology · 2021-06-29 · Review

    current
  31. Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist.

    Pickford P, Lucey M, Rujan RM, McGlone ER, Bitsi S, Ashford FB, Corrêa IR, Hodson DJ, Tomas A, Deganutti G, Reynolds CA, Owen BM, Tan TM, Minnion J, Jones B, Bloom SR

    Molecular metabolism · 2021-04-30 · Journal Article

    current
  32. Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling.

    Israeli H, Degtjarik O, Fierro F, Chunilal V, Gill AK, Roth NJ, Botta J, Prabahar V, Peleg Y, Chan LF, Ben-Zvi D, McCormick PJ, Niv MY, Shalev-Benami M

    Science (New York, N.Y.) · 2021-04-15 · Journal Article

    current
  33. AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists.

    Fletcher MM, Keov P, Truong TT, Mennen G, Hick CA, Zhao P, Furness SGB, Kruse T, Clausen TR, Wootten D, Sexton PM

    The Journal of pharmacology and experimental therapeutics · 2021-03-16 · Journal Article

    current
  34. Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.

    Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, Sloop KW

    Proceedings of the National Academy of Sciences of the United States of America · 2020-11-11 · Journal Article

    current
  35. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.

    Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, Urva S, Emmerson PJ, Holst JJ, D'Alessio DA, Coghlan MP, Rosenkilde MM, Campbell JE, Sloop KW

    JCI insight · 2020-09-03 · Journal Article

    current
  36. Palmitate differentially regulates Spexin, and its receptors Galr2 and Galr3, in GnRH neurons through mechanisms involving PKC, MAPKs, and TLR4.

    Wang L, Tran A, Lee J, Belsham DD

    Molecular and cellular endocrinology · 2020-08-22 · Journal Article

    current
  37. Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode.

    Shiimura Y, Horita S, Hamamoto A, Asada H, Hirata K, Tanaka M, Mori K, Uemura T, Kobayashi T, Iwata S, Kojima M

    Nature communications · 2020-08-19 · Journal Article

    current
  38. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors.

    Darbalaei S, Yuliantie E, Dai A, Chang R, Zhao P, Yang D, Wang MW, Sexton PM, Wootten D

    Biochemical pharmacology · 2020-07-17 · Journal Article

    current
  39. Determination of the melanocortin-4 receptor structure identifies Ca(2+) as a cofactor for ligand binding.

    Yu J, Gimenez LE, Hernandez CC, Wu Y, Wein AH, Han GW, McClary K, Mittal SR, Burdsall K, Stauch B, Wu L, Stevens SN, Peisley A, Williams SY, Chen V, Millhauser GL, Zhao S, Cone RD, Stevens RC

    Science (New York, N.Y.) · 2020-04-24 · Journal Article

    current
  40. Semaglutide lowers body weight in rodents via distributed neural pathways.

    Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nøhr J, Lu TT, Polex-Wolf J, Prevot V, Raun K, Simonsen L, Sun G, Szilvásy-Szabó A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ

    JCI insight · 2020-03-26 · Journal Article

    current
  41. Structural basis of G(s) and G(i) recognition by the human glucagon receptor.

    Qiao A, Han S, Li X, Li Z, Zhao P, Dai A, Chang R, Tai L, Tan Q, Chu X, Ma L, Thorsen TS, Reedtz-Runge S, Yang D, Wang MW, Sexton PM, Wootten D, Sun F, Zhao Q, Wu B

    Science (New York, N.Y.) · 2020-03-20 · Journal Article

    current
  42. How May GIP Enhance the Therapeutic Efficacy of GLP-1?

    Samms RJ, Coghlan MP, Sloop KW

    Trends in endocrinology and metabolism: TEM · 2020-03-16 · Review

    current
  43. Full-length human GLP-1 receptor structure without orthosteric ligands.

    Wu F, Yang L, Hang K, Laursen M, Wu L, Han GW, Ren Q, Roed NK, Lin G, Hanson MA, Jiang H, Wang MW, Reedtz-Runge S, Song G, Stevens RC

    Nature communications · 2020-03-09 · Journal Article

    current
  44. Peptide Regulation of Cell Differentiation.

    Khavinson V, Linkova N, Diatlova A, Trofimova S

    Stem cell reviews and reports · 2020-02 · Review

    current
  45. The Discovery and Development of Liraglutide and Semaglutide.

    Knudsen LB, Lau J

    Frontiers in endocrinology · 2019-04-12 · Review

    current
  46. current
  47. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.

    Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, D'Alessio DA, Haupt A

    Molecular metabolism · 2018-10-03 · Journal Article

    current
  48. Structure of the glucagon receptor in complex with a glucagon analogue.

    Zhang H, Qiao A, Yang L, Van Eps N, Frederiksen KS, Yang D, Dai A, Cai X, Zhang H, Yi C, Cao C, He L, Yang H, Lau J, Ernst OP, Hanson MA, Stevens RC, Wang MW, Reedtz-Runge S, Jiang H, Zhao Q, Wu B

    Nature · 2018-01-03 · Journal Article

    current
  49. Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.

    Nairz M, Haschka D, Dichtl S, Sonnweber T, Schroll A, Aßhoff M, Mindur JE, Moser PL, Wolf D, Swirski FK, Theurl I, Cerami A, Brines M, Weiss G

    Scientific reports · 2017-10-12 · Journal Article

    current
  50. AMPK: guardian of metabolism and mitochondrial homeostasis.

    Herzig S, Shaw RJ

    Nature reviews. Molecular cell biology · 2017-10-04 · Review

    current
  51. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.

    Zhang Y, Sun B, Feng D, Hu H, Chu M, Qu Q, Tarrasch JT, Li S, Sun Kobilka T, Kobilka BK, Skiniotis G

    Nature · 2017-05-24 · Journal Article

    current
  52. Structure of the full-length glucagon class B G-protein-coupled receptor.

    Zhang H, Qiao A, Yang D, Yang L, Dai A, de Graaf C, Reedtz-Runge S, Dharmarajan V, Zhang H, Han GW, Grant TD, Sierra RG, Weierstall U, Nelson G, Liu W, Wu Y, Ma L, Cai X, Lin G, Wu X, Geng Z, Dong Y, Song G, Griffin PR, Lau J, Cherezov V, Yang H, Hanson MA, Stevens RC, Zhao Q, Jiang H, Wang MW, Wu B

    Nature · 2017-05-17 · Journal Article

    current
  53. Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries.

    Zhang Y, Chen W, Wu Y, Yang B

    Current protein & peptide science · 2017 · Review

    current
  54. Amyloidogenesis of the amylin analogue pramlintide.

    da Silva DC, Fontes GN, Erthal LC, Lima LM

    Biophysical chemistry · 2016-09-20 · Journal Article

    current
  55. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.

    Kumar N, Nakagawa P, Janic B, Romero CA, Worou ME, Monu SR, Peterson EL, Shaw J, Valeriote F, Ongeri EM, Niyitegeka JM, Rhaleb NE, Carretero OA

    American journal of physiology. Renal physiology · 2016-03-09 · Journal Article

    current
  56. current
  57. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.

    Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T

    Journal of medicinal chemistry · 2015-09-11 · Journal Article

    current
  58. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

    Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen P

    Cell metabolism · 2015-03-03 · Journal Article

    current
  59. Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

    González-Sales M, Barrière O, Tremblay PO, Nekka F, Mamputu JC, Boudreault S, Tanguay M

    Clinical pharmacokinetics · 2015-03 · Journal Article

    current
  60. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

    Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L

    The Journal of clinical investigation · 2014-09-09 · Journal Article

    current
  61. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.

    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K

    Neurobiology of disease · 2014-07-15 · Journal Article

    current
  62. Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS).

    Choi YL, Park EJ, Kim E, Na DH, Shin YH

    Biomolecules & therapeutics · 2014-07 · Journal Article

    current
  63. Self-assembly of palmitoyl lipopeptides used in skin care products.

    Castelletto V, Hamley IW, Whitehouse C, Matts PJ, Osborne R, Baker ES

    Langmuir : the ACS journal of surfaces and colloids · 2013-07-12 · Journal Article

    current
  64. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.

    Zuo Y, Chun B, Potthoff SA, Kazi N, Brolin TJ, Orhan D, Yang HC, Ma LJ, Kon V, Myöhänen T, Rhaleb NE, Carretero OA, Fogo AB

    Kidney international · 2013-06-05 · Journal Article

    current
  65. Pharmacology, physiology, and mechanisms of incretin hormone action.

    Campbell JE, Drucker DJ

    Cell metabolism · 2013-05-16 · Review

    current
  66. The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.

    Kosinski JR, Hubert J, Carrington PE, Chicchi GG, Mu J, Miller C, Cao J, Bianchi E, Pessi A, Sinharoy R, Marsh DJ, Pocai A

    Obesity (Silver Spring, Md.) · 2012-03-16 · Journal Article

    current
  67. Topically applied KTTKS: a review.

    Abu Samah NH, Heard CM

    International journal of cosmetic science · 2011-05-03 · Review

    current
  68. Ghrelin and glucose homeostasis.

    Delhanty PJ, van der Lely AJ

    Peptides · 2011-03-21 · Review

    current
  69. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.

    Thomas A, Höppner S, Geyer H, Schänzer W, Petrou M, Kwiatkowska D, Pokrywka A, Thevis M

    Analytical and bioanalytical chemistry · 2011-02-06 · Journal Article

    current
  70. Tesamorelin.

    Grunfeld C, Dritselis A, Kirkpatrick P

    Nature reviews. Drug discovery · 2011-02 · News

    current
  71. Use of chimeric melanocortin-2 and -4 receptors to identify regions responsible for ligand specificity and dependence on melanocortin 2 receptor accessory protein.

    Hinkle PM, Serasinghe MN, Jakabowski A, Sebag JA, Wilson KR, Haskell-Luevano C

    European journal of pharmacology · 2011-01-03 · Journal Article

    current
  72. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

    Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH

    Journal of applied physiology (Bethesda, Md. : 1985) · 2010-10-28 · Journal Article

    current
  73. Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.

    Li B, Wanka L, Blanchard J, Liu F, Chohan MO, Iqbal K, Grundke-Iqbal I

    FEBS letters · 2010-06-30 · Journal Article

    current
  74. Thymosin beta4 and its posttranslational modifications.

    Hannappel E

    Annals of the New York Academy of Sciences · 2010-04 · Review

    current
  75. Structural basis for ligand recognition of incretin receptors.

    Underwood CR, Parthier C, Reedtz-Runge S

    Vitamins and hormones · 2010 · Review

    current
  76. Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics.

    Chirita RI, Chaimbault P, Archambault JC, Robert I, Elfakir C

    Analytica chimica acta · 2009-03-20 · Journal Article

    current
  77. Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling.

    Yang Y, Cai M, Chen M, Qu H, McPherson D, Hruby V, Harmon CM

    Regulatory peptides · 2009-03-20 · Journal Article

    current
  78. Tesamorelin, a human growth hormone releasing factor analogue.

    Wang Y, Tomlinson B

    Expert opinion on investigational drugs · 2009-03 · Review

    current
  79. A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams.

    Nonoyama A, Laurence JS, Garriques L, Qi H, Le T, Middaugh CR

    Journal of pharmaceutical sciences · 2008-07 · Journal Article

    current
  80. The human tri-peptide GHK and tissue remodeling.

    Pickart L

    Journal of biomaterials science. Polymer edition · 2008 · Review

    current
  81. The beta-thymosin enigma.

    Sun HQ, Yin HL

    Annals of the New York Academy of Sciences · 2007-05-10 · Review

    current
  82. beta-Thymosins.

    Hannappel E

    Annals of the New York Academy of Sciences · 2007-04-27 · Review

    current
  83. Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.

    Tomlinson B

    Current opinion in investigational drugs (London, England : 2000) · 2006-10 · Review

    current
  84. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

    Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R

    American journal of physiology. Endocrinology and metabolism · 2006-07-05 · Journal Article

    current
  85. GPR54 and kisspeptin in reproduction.

    Tena-Sempere M

    Human reproduction update · 2006-05-26 · Review

    current
  86. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

    Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA

    The Journal of clinical endocrinology and metabolism · 2005-12-13 · Journal Article

    current
  87. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

    Pogozheva ID, Chai BX, Lomize AL, Fong TM, Weinberg DH, Nargund RP, Mulholland MW, Gantz I, Mosberg HI

    Biochemistry · 2005-08-30 · Journal Article

    current
  88. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

    Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP

    Endocrinology · 2005-04-07 · Journal Article

    current
  89. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study.

    Demers A, McNicoll N, Febbraio M, Servant M, Marleau S, Silverstein R, Ong H

    The Biochemical journal · 2004-09-01 · Journal Article

    current
  90. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.

    Cavasin MA, Rhaleb NE, Yang XP, Carretero OA

    Hypertension (Dallas, Tex. : 1979) · 2004-03-22 · Journal Article

    current
  91. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.

    Getting SJ, Schiöth HB, Perretti M

    The Journal of pharmacology and experimental therapeutics · 2003-05-15 · Journal Article

    current
  92. New active series of growth hormone secretagogues.

    Guerlavais V, Boeglin D, Mousseaux D, Oiry C, Heitz A, Deghenghi R, Locatelli V, Torsello A, Ghé C, Catapano F, Muccioli G, Galleyrand JC, Fehrentz JA, Martinez J

    Journal of medicinal chemistry · 2003-03-27 · Journal Article

    current
  93. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

    Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL, Lamontagne D, Ong H

    Circulation research · 2002-05-03 · Journal Article

    current
  94. Peptides and Ageing.

    Khavinson VKh

    Neuro endocrinology letters · 2002 · Review

    current
  95. 1H NMR structural analysis of human ghrelin and its six truncated analogs.

    Silva Elipe MV, Bednarek MA, Gao YD

    Biopolymers · 2001-12 · Journal Article

    current
  96. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.

    Hansen TK, Ankersen M, Raun K, Hansen BS

    Bioorganic & medicinal chemistry letters · 2001-07-23 · Journal Article

    current
  97. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54.

    Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M

    The Journal of biological chemistry · 2001-07-16 · Journal Article

    current
  98. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1.

    Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC

    The Journal of biological chemistry · 2001-05-31 · Journal Article

    current
  99. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.

    Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M

    Nature · 2001-05-31 · Journal Article

    current
  100. Growth hormone secretagogue receptor family members and ligands.

    Smith RG, Leonard R, Bailey AR, Palyha O, Feighner S, Tan C, Mckee KK, Pong SS, Griffin P, Howard A

    Endocrine · 2001-02 · Review

    current
  101. Actin dynamics.

    Pollard TD, Blanchoin L, Mullins RD

    Journal of cell science · 2001-01 · Journal Article

    current
  102. The neuroimmunomodulatory peptide alpha-MSH.

    Ichiyama T, Sato S, Okada K, Catania A, Lipton JM

    Annals of the New York Academy of Sciences · 2000 · Review

    current
  103. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

    Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K

    Nature · 1999-12-09 · Journal Article

    current
  104. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.

    Moriarty DF, Raleigh DP

    Biochemistry · 1999-02-09 · Journal Article

    current
  105. Structure-function studies on the cyclic peptide MT-II, lactam derivative of alpha-melanotropin.

    Bednarek MA, Silva MV, Arison B, MacNeil T, Kalyani RN, Huang RR, Weinberg DH

    Peptides · 1999 · Journal Article

    current
  106. Ipamorelin, the first selective growth hormone secretagogue.

    Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH

    European journal of endocrinology · 1998-11 · Journal Article

    current
  107. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.

    Yang Yk, Dickinson C, Haskell-Luevano C, Gantz I

    The Journal of biological chemistry · 1997-09-12 · Journal Article

    current
  108. SPARC is a source of copper-binding peptides that stimulate angiogenesis.

    Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH

    The Journal of cell biology · 1994-05 · Journal Article

    current
  109. A pentapeptide from type I procollagen promotes extracellular matrix production.

    Katayama K, Armendariz-Borunda J, Raghow R, Kang AH, Seyer JM

    The Journal of biological chemistry · 1993-05-15 · Journal Article

    current
  110. Exendin peptides.

    Eng J

    The Mount Sinai journal of medicine, New York · 1992-03 · Journal Article

    current
  111. Anti-inflammatory activity of alpha-MSH(11-13) analogs: influences of alteration in stereochemistry.

    Hiltz ME, Catania A, Lipton JM

    Peptides · 1991-07 · Journal Article

    current
  112. Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation.

    Miller DM, DeSilva D, Pickart L, Aust SD

    Advances in experimental medicine and biology · 1990 · Journal Article

    current
  113. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.

    Blache P, Kervran A, Martinez J, Bataille D

    Analytical biochemistry · 1988-08-15 · Journal Article

    current
  114. Glucagon-like peptide-1 7-36: a physiological incretin in man.

    Kreymann B, Williams G, Ghatei MA, Bloom SR

    Lancet (London, England) · 1987-12-05 · Journal Article

    current
  115. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

    Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB

    Proceedings of the National Academy of Sciences of the United States of America · 1987-12 · Journal Article

    current
  116. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

    Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH

    Proceedings of the National Academy of Sciences of the United States of America · 1987-06 · Journal Article

    current
  117. current
  118. The isolation and sequencing of human gastric inhibitory peptide (GIP).

    Moody AJ, Thim L, Valverde I

    FEBS letters · 1984-07-09 · Journal Article

    current
  119. Delta-sleep-inducing peptide (DSIP): a review.

    Graf MV, Kastin AJ

    Neuroscience and biobehavioral reviews · 1984 · Review

    current
  120. Structure of the Glycyl-L-histidyl-L-lysine--copper(II) complex in solution.

    Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J

    Biochemistry · 1982-09-14 · Journal Article

    current
  121. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma.

    Lau SJ, Sarkar B

    The Biochemical journal · 1981-12-01 · Journal Article

    current
  122. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

    Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB, Hadley ME

    Proceedings of the National Academy of Sciences of the United States of America · 1980-10 · Journal Article

    current
  123. The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptide.

    Schoenenberger GA, Maier PF, Tobler HJ, Wilson K, Monnier M

    Pflugers Archiv : European journal of physiology · 1978-09-06 · Journal Article

    current
  124. Growth-modulating serum tripeptide is glycyl-histidyl-lysine.

    Schlesinger DH, Pickart L, Thaler MM

    Experientia · 1977-03-15 · Journal Article

    current